NO20083480L - Piperidinoylpyrrolidiner som melanokortin type 4 reseptor agonister - Google Patents

Piperidinoylpyrrolidiner som melanokortin type 4 reseptor agonister

Info

Publication number
NO20083480L
NO20083480L NO20083480A NO20083480A NO20083480L NO 20083480 L NO20083480 L NO 20083480L NO 20083480 A NO20083480 A NO 20083480A NO 20083480 A NO20083480 A NO 20083480A NO 20083480 L NO20083480 L NO 20083480L
Authority
NO
Norway
Prior art keywords
piperidinoylpyrrolidines
receptor agonists
melanocortin
melanocortin type
type
Prior art date
Application number
NO20083480A
Other languages
English (en)
Norwegian (no)
Inventor
Mark David Andrews
Alan Daniel Brown
Mark Ian Landsdell
Nicholas William Summerhill
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of NO20083480L publication Critical patent/NO20083480L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20083480A 2006-02-23 2008-08-11 Piperidinoylpyrrolidiner som melanokortin type 4 reseptor agonister NO20083480L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77629506P 2006-02-23 2006-02-23
US88784007P 2007-02-02 2007-02-02
PCT/IB2007/000456 WO2007096763A2 (en) 2006-02-23 2007-02-19 Melanocortin type 4 receptor agonist piperidinoylpyrrolidines

Publications (1)

Publication Number Publication Date
NO20083480L true NO20083480L (no) 2008-09-10

Family

ID=38169450

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083480A NO20083480L (no) 2006-02-23 2008-08-11 Piperidinoylpyrrolidiner som melanokortin type 4 reseptor agonister

Country Status (21)

Country Link
US (1) US8138188B2 (es)
EP (1) EP1989196B1 (es)
KR (1) KR101036981B1 (es)
AP (1) AP2008004602A0 (es)
AU (1) AU2007219236B2 (es)
BR (1) BRPI0708264A2 (es)
CA (1) CA2642922C (es)
CR (1) CR10219A (es)
DK (1) DK1989196T3 (es)
EA (1) EA200801738A1 (es)
EC (1) ECSP088688A (es)
ES (1) ES2402581T3 (es)
IL (1) IL193279A (es)
MA (1) MA30228B1 (es)
ME (1) MEP6808A (es)
MX (1) MX2008010899A (es)
NO (1) NO20083480L (es)
RS (1) RS20080371A (es)
SG (1) SG185849A1 (es)
TN (1) TNSN08337A1 (es)
WO (1) WO2007096763A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2019100A1 (en) * 2007-07-19 2009-01-28 Santhera Pharmaceuticals (Schweiz) AG Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8737295B2 (en) 2007-11-16 2014-05-27 Qualcomm Incorporated Sector identification using sector parameters signatures
US9603062B2 (en) 2007-11-16 2017-03-21 Qualcomm Incorporated Classifying access points using pilot identifiers
US8848656B2 (en) 2007-11-16 2014-09-30 Qualcomm Incorporated Utilizing broadcast signals to convey restricted association information
US8902867B2 (en) 2007-11-16 2014-12-02 Qualcomm Incorporated Favoring access points in wireless communications
EP2103614A1 (en) * 2008-03-18 2009-09-23 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
US8588773B2 (en) 2008-08-04 2013-11-19 Qualcomm Incorporated System and method for cell search and selection in a wireless communication system
UA99555C2 (en) 2008-11-12 2012-08-27 Элджи Лайф Саенсез Лтд. Melanocortin receptor agonists
PT2722045T (pt) 2009-11-18 2016-10-18 Helsinn Healthcare Sa Composições para o tratamento de náuseas e vómitos mediadas centralmente
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
PL3333165T3 (pl) 2015-08-04 2019-12-31 Astellas Pharma Inc. Pochodne piperazyny
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
MX2022015706A (es) 2020-06-09 2023-01-24 Pfizer Antagonistas del receptor de melanocortina 4 y usos de estos.
ES3039638T3 (en) 2021-12-06 2025-10-23 Pfizer Melanocortin 4 receptor antagonists and uses thereof
WO2025228902A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Heterocyclic acids as sting antagonists and the use thereof as medicament
WO2025228900A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Arylamide substituted indazoles and the use thereof as medicament
WO2025228899A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Further heterocyclic compounds as sting antagonists and the use thereof as medicament
US20250333398A1 (en) 2024-04-30 2025-10-30 Boehringer Ingelheim International Gmbh Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament
WO2025228895A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament
WO2025228889A1 (en) 2024-04-30 2025-11-06 Boehringer Ingelheim International Gmbh Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament
US12605394B2 (en) 2024-07-25 2026-04-21 Visionary Assets, Llc Compositions containing cannabinoid nanoparticles

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
US5274143A (en) * 1991-07-23 1993-12-28 Hoffmann-La Roche Inc. Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
US5596106A (en) * 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
US5521186A (en) * 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors
DE69519995T2 (de) * 1994-10-27 2001-08-23 Janssen Pharmaceutica Nv Apolipoprotein-b syntheseinhibitoren
WO2000035298A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing gum containing medicament active agents
IL141769A0 (en) * 1998-09-11 2002-03-10 Aventis Pharma Sa Azetidine derivatives, preparation and medicines containing them
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
US8273713B2 (en) 2000-12-14 2012-09-25 Amylin Pharmaceuticals, Llc Methods of treating obesity using PYY[3-36]
IL157253A0 (en) * 2001-02-28 2004-02-19 Merck & Co Inc Acylated piperidine derivatives as melanocortin-4 receptor agonists
DE60215132T2 (de) 2001-02-28 2007-08-23 Merck & Co., Inc. Acylierte piperidin-derivate als melanocortin-4-rezeptor-agonisten
SK287592B6 (sk) 2001-03-22 2011-03-04 Solvay Pharmaceuticals B. V. 4,5-Dihydro-1H-pyrazolové deriváty, ktoré majú CB1-antagonistickú účinnosť, spôsob ich prípravy a použitie
WO2003027637A2 (en) 2001-09-24 2003-04-03 Oregon Health And Science University Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
WO2003075660A1 (en) 2002-03-06 2003-09-18 Merck & Co., Inc. Method of treatment or prevention of obesity
AU2003250117B2 (en) 2002-07-29 2007-05-10 F. Hoffmann-La Roche Ag Novel benzodioxoles
EP1558252B1 (en) 2002-08-02 2007-10-10 Merck & Co., Inc. Substituted furo [2,3-b]pyridine derivatives
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
MY134457A (en) 2002-11-22 2007-12-31 Merck & Co Inc Substituted amides
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7151097B2 (en) * 2003-11-07 2006-12-19 Pfizer Inc. Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
GB0402492D0 (en) * 2004-02-04 2004-03-10 Pfizer Ltd Pharmaceutically active compounds
WO2007015162A1 (en) * 2005-08-04 2007-02-08 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
JP5530438B2 (ja) 2008-08-06 2014-06-25 ファイザー・リミテッド Ｍｃ４作動薬としてのジアゼピンおよびジアゾカン化合物

Also Published As

Publication number Publication date
AU2007219236B2 (en) 2012-06-21
KR101036981B1 (ko) 2011-05-25
CR10219A (es) 2008-09-23
ES2402581T3 (es) 2013-05-06
AU2007219236A1 (en) 2007-08-30
US20090036459A1 (en) 2009-02-05
DK1989196T3 (da) 2013-04-15
IL193279A (en) 2012-12-31
MEP6808A (xx) 2010-02-10
BRPI0708264A2 (pt) 2011-05-24
EP1989196A2 (en) 2008-11-12
SG185849A1 (en) 2012-12-28
EP1989196B1 (en) 2013-02-13
HK1126489A1 (en) 2009-09-04
IL193279A0 (en) 2009-02-11
CA2642922A1 (en) 2007-08-30
ECSP088688A (es) 2008-10-31
WO2007096763A2 (en) 2007-08-30
EA200801738A1 (ru) 2008-12-30
MX2008010899A (es) 2008-11-27
CA2642922C (en) 2011-08-02
TNSN08337A1 (fr) 2009-12-29
MA30228B1 (fr) 2009-02-02
WO2007096763A3 (en) 2007-10-18
US8138188B2 (en) 2012-03-20
KR20080095918A (ko) 2008-10-29
RS20080371A (sr) 2009-07-15
AP2008004602A0 (en) 2008-10-31

Similar Documents

Publication Publication Date Title
NO20083480L (no) Piperidinoylpyrrolidiner som melanokortin type 4 reseptor agonister
UA84208C2 (en) Tetraazabenzo(e)azulene derivatives and analogs thereof
MA31084B1 (fr) Derives de piperidine agonistes de gpcr
NO20092412L (no) Hydantoinderivater anvendes som MMP-inhibitorer
IL187005A0 (en) Diacylglycerol acyltransferase inhibitors
NO20073663L (no) Tiazol-4-karboksamid-derivater som mGluR5 antagonister
NO20070606L (no) Inhibitorer av IAP
NO20082445L (no) Neuropeptid-2 reseptor-agonister
CY1110900T1 (el) Χημικες ενωσεις
NO20076479L (no) Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer
NO20081217L (no) Nye benzotiazolonderivater
NO20050741L (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
UA97257C2 (en) Indole derivatives
ATE390922T1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
NO20076478L (no) Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
NO20082096L (no) Azaindol-2-karboksamidderivativer
MX2010002938A (es) Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
NO20076680L (no) Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
NO20090779L (no) 5,6-bisaryl-2-pyridin-karboksamidderivater, fremstilling og anvendelse derav i terapeutika som uretosin II receptorantagonister
NO20092092L (no) Arylsulfamidderivater og fremgangsmater for anvendelse derav
NO20090073L (no) 1,3-disubstitue 4-metyl-1H-pyrol-2-karboksamider og deres anvendelse for fremstlling av medikamenter
TW200700069A (en) Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
NO20082214L (no) 1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application